Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Merck (MRK) shares are moving after it raised its full-year profit forecast after third-quarter results topped Wall Street’s expectations, fueled by stronger-than-anticipated sales of cancer blockbuster Keytruda and other newer medicines. The company boosted the lower end of its full-year sales forecast by $500 million and now expects adjusted earnings for the year of $2.77 to $2.82 a share. Sales of Keytruda in both its formulations combined were $8.6 billion, and the company is also developing a growing pipeline of experimental drugs, including a personalized skin cancer vaccine and sacituzumab tirumotecan.
- Caterpillar (CAT) shares are moving after it posted quarterly earnings that beat Wall Street expectations as demand for the company's power-generation equipment continued to drive sales. The company's power and energy segment has grown into its largest business by sales, driven by technology companies' need for infrastructure to meet AI's enormous electricity demand.
- Microsoft (MSFT) is higher this morning while Google-parent Alphabet (GOOG) is lower after reporting earnings yesterday. Microsoft gained after the software company’s first-quarter results beat expectations on key metrics, including growth in its Azure cloud-computing business. Alphabet, meanwhile, dropped after the Google parent’s third-quarter results featured weaker-than-expected revenue for both Google advertising and search, which offset strong growth in its cloud business. Analysts said the report adds to concerns about AI disrupting search and related businesses.
- Marvell Technology (MRVL) shares are moving on news the company is in advanced talks to buy Lumentum, a data center optics maker, according to people familiar with the matter. A transaction may be announced as soon as next week, with Lumentum having a market value of about $83 billion and Marvell worth around $221 billion.
See omnystudio.com/listener for privacy information.